
Major Study Confirms Racial Disparities Related to Key Diabetes Indicator, Hemoglobin A1c
Major Study Confirms Racial Disparities Related to Key Diabetes Indicator, Hemoglobin A1c
Standard Test for Determining Blood Sugar Control in People with Diabetes Is Not Always an Accurate Measure of Blood Sugar Control and Interpretation Differs Based on Race.
Boston, MA – June 14, 2017 – T1D Exchange, an organization that is accelerating novel treatments and improving care, today published an important research study that confirms disparities between blacks and whites in hemoglobin A1c (HbA1c) levels, the standard measure used to assess blood sugar control in people with diabetes. Racial differences in HbA1c levels have been consistently reported in adults and children with type 1 diabetes (T1D) or type 2 diabetes, with non-Hispanic blacks having higher A1c levels than non-Hispanic whites. T1D Exchange researchers sought to understand whether this difference is due to worse glycemic control in blacks or the consequence of racial differences in the glycation of hemoglobin.
This study builds upon previous T1D Exchange research that identified racial disparities in glucose control, with blacks having higher HbA1c levels than whites in both children and adults. In the scientific community, differing theories have been proposed regarding these disparities; that higher HbA1c levels in blacks represents worse glycemic control; and that higher HbA1c levels could be due to race-based genetic differences in the glycation of hemoglobin at the same glucose levels. If the latter were true, it would mean that HbA1c on average is overestimating the mean glucose concentration in bla
Continue
reading